SCHEMBL6533411

SCHEMBL6533411

COc1ccc(C(NO)C(N)=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.50
CA2 P00918 5/20 0.50
PARP10 Q53GL7 2/20 0.50
PARP1 P09874 1/20 0.50
PARP2 Q9UGN5 1/20 0.50
PARP4 Q9UKK3 1/20 0.50
ALOX5 P09917 1/20 0.47
RAB9A P51151 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
AOC3 Q16853 1/20 0.46
ACHE P22303 1/20 0.45
ADRB3 P13945 2/20 0.44
NPC1 O15118 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30336247 0.85 ATM (0.51) CA1CA2RAB9ANPSR1MEN1
SCHEMBL4593652 0.80 CA1 (0.57) CA1CA2PARP10PARP1PARP2
SCHEMBL6532996 0.79 PEPD (0.42) CA2PARP10KMT2A
SCHEMBL4507705 0.79 CA1 (0.55) CA1CA2PARP10PARP1PARP2
SCHEMBL5173278 0.78 NPSR1 (0.49) CA1CA2NPSR1AOC3ADRB3
SCHEMBL11646318 0.77 ATM (0.55) CA1CA2PARP10PARP1PARP2
SCHEMBL2879729 0.77 CNR2 (0.62) CA1CA2MEN1KMT2ANPC1
SCHEMBL2879728 0.77 CNR2 (0.62) CA1CA2MEN1KMT2ANPC1
SCHEMBL13683338 0.77 LMNA (0.51) CA1CA2PARP10PARP1PARP2
SCHEMBL1354444 0.77 CA1 (0.53) CA1CA2PARP10PARP1PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575933-A1 ENANTIOMERS OF THIOPHENE HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HDAC INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2005-09-21 EP disclosed
WO-2004054999-A1 ENANTIOMERS OF THIOPHENE HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HDAC INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-01 WO disclosed